Study evaluates effectiveness and safety of TMF for chronic hepatitis B
The Future of Hepatitis B Treatment: What to Expect in 2023 and Beyond Evolving Therapies: Beyond Tenofovir The landscape of chronic hepatitis B (CHB) treatment is undergoing a significant transformation. With the emergence of tenofovir amibufenamide (TMF), patients are witnessing a shift towards more targeted and safer treatment options. Unlike its predecessor, TDF, TMF boasts … Read more